Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

543 results

The ARC consensus on DCB - evidence-based DCB technology

15 May 2024 – From EuroPCR 2024

In this replay, discover why DCBs are essential in treating de novo CAD, the importance of optimal lesion preparation for long-term success, and how future trials will focus on treatment strategies rather than device comparisons, highlighting the need for further research.

Evidence-based on DCB technology that have dictated the ARC consensus on DCB

Tools and technologies guiding decision making in bifurcation PCI

15 May 2024 – From EuroPCR 2024

In this session, discover that provisional stenting in routine non-LM bifurcation using Resolute Onyx DES yields good mid-term outcomes without side branch intervention, provided the stent is sized to the distal reference and the side branch remains patent after a systematic POT. Learn how bifurcation stenting...

Tools and technologies guiding decision making in bifurcation PCI

How do I confidently expand my DCB practice?

15 May 2024 – From EuroPCR 2024

This session offers insights on identifying appropriate lesions for DCB treatment, understanding the essential concepts for achieving optimal immediate results with DCB PCI, and exploring the long-term angiographic and clinical outcomes. The session emphasizes the importance of lesion preparation, notes that there are no contraindications for...

How do I confidently expand my DCB practice?

Complex PCI in ACS patient with high bleeding risk: optimise the strategy

15 May 2024 – From EuroPCR 2024

Watch this session for insights into managing acute coronary syndrome patients with multivessel disease, updates on treatment approaches, comparing FULL RESVAC with previous trials like COMPLETE or FIRE, for example, and information on ongoing trials such as FRAMI-AMI 2 and 3. Explore the LIVE case presentation...

Complex PCI in ACS patient with high bleeding risk: optimise the strategy

Randomised trials: substudies and extended follow-up - A quick update

15 May 2024 – From EuroPCR 2024

This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...

Randomised trials: substudies and extended follow-up - A quick update

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

14 May 2024 – From EuroPCR 2024

Discover the remarkable performance of Supraflex Cruz in real-world clinical settings, showcasing exceptionally low event rates and demonstrating its safety and efficacy across a spectrum of high-risk patients, including the elderly and those with high bleeding risks, and delve into the ongoing TALENT and TUDEXO II...

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

Hotline: new coronary devices (DES, BRS, DCB)

14 May 2024 – From EuroPCR 2024

This hotline session provides a comprehensive overview of the latest clinical data on new coronary devices, including bioresorbable scaffolds, drug-coated balloons, and drug-eluting stents. Participants will learn about the outcomes of various randomized trials and registry studies, examining the performance of these innovative technologies in different...

Hotline: New Coronary Devices Unveiled

Treatment strategies of calcified lesions

14 May 2024 – From EuroPCR 2024

This session, comprising selected EuroPCR 2024 Abstract submissions, explores various treatment strategies for calcified coronary lesions. It includes presentations and discussions on the invasive evaluation of coronary artery compliance modification after intracoronary lithotripsy, a retrospective comparison of rotational atherectomy in NSTE-ACS and stable angina patients, the...

Treatment strategies of calcified lesions

Challenging situations and complications in patients with ACS and acute heart failure undergoing PCI

14 May 2024 – From EuroPCR 2024

This session, with the collaboration of various national societies, focuses on understanding different approaches and techniques for managing challenging situations and complications in patients with ACS and acute heart failure undergoing PCI. It covers the prompt recognition of potential periprocedural complications, various management strategies for PCI...

Challenging situations and complications in patients with ACS and acute heart failure undergoing PCI

Expanding the indications of DCB for complex PCI scenarios

14 May 2024 – From EuroPCR 2024

This session, with the collaboration of various national societies, explores the use of drug-coated balloons (DCBs) in complex PCI scenarios, such as multivessel disease, left main, bifurcations, CTOs, or myocardial infarction. It includes case presentations and discussions on the procedural techniques, patient selection, and lesion preparation...

Expanding the indications of DCB for complex PCI scenarios